patent/UA-101665-C2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-101665-C2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04a9c30b01a6909696dc92e883f241c
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
filingDate	2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dde923005747bacf0834481515b2f7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f177358bf7c9d26ce984988c28a49188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1f1f38b408ecb996c97e4869cdf5cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24082df5cb13ee83c48526ff5325650 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0788ed2b75680b5dbb961d936d50034a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2862bced6101eef1e37fdcbd0128b901
publicationDate	2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-101665-C2
titleOfInvention	ANALGETIC TOLERANCE AND CONSTITUTION INHIBITOR [ANALGETIC TOLERANCE INHIBITOR AND CONSTITUTION
abstract	The invention relates to an agent for suppressing the undesirable effects of an opioid, which is selected from analgesic tolerance or constipation, which contains a compound with antagonistic activity to the adenosine Areceptor or its pharmaceutically acceptable salt.
priorityDate	2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448378 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432787922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447916 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554679

Total number of triples: 32.